Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

Authors: Vivek Subbiah, Robert J. Kreitman, Zev A. Wainberg, Y. Choi, Jan H.M. Schellens, Jean‐Charles Soria, Patrick Y. Wen, C. C. Zielinski, Maria E. Cabanillas, Aislyn Boran, Palanichamy Ilankumaran, P. Burgess, T. Romero Salas, Bhumsuk Keam - Annals of Oncology 2022 cited by 346